These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


473 related items for PubMed ID: 16628716

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. [Clinical characteristics and prognosis of diffuse large B-cell lymphoma].
    Yang BY, Yong WB, Zhu J, Zheng W, Zhang YT, Wang XP, Meng SN.
    Zhonghua Zhong Liu Za Zhi; 2005 Mar; 27(3):174-6. PubMed ID: 15946571
    [Abstract] [Full Text] [Related]

  • 5. Clinical relevance of immunophenotype in a retrospective comparative study of 297 peripheral T-cell lymphomas, unspecified, and 496 diffuse large B-cell lymphomas: experience of the Intergruppo Italiano Linformi.
    Morabito F, Gallamini A, Stelitano C, Callea V, Guglielmi C, Neri S, Lazzaro A, Orsucci L, Ilariucci F, Sacchi S, Vitolo U, Federico M.
    Cancer; 2004 Oct 01; 101(7):1601-8. PubMed ID: 15378507
    [Abstract] [Full Text] [Related]

  • 6. Primary cutaneous diffuse large B-cell lymphoma, leg type: clinicopathologic features and prognostic analysis in 60 cases.
    Grange F, Beylot-Barry M, Courville P, Maubec E, Bagot M, Vergier B, Souteyrand P, Machet L, Dalac S, Esteve E, Templier I, Delaporte E, Avril MF, Robert C, Dalle S, Laroche L, Delaunay M, Joly P, Wechsler J, Petrella T.
    Arch Dermatol; 2007 Sep 01; 143(9):1144-50. PubMed ID: 17875875
    [Abstract] [Full Text] [Related]

  • 7. Presence of a high-grade component in gastric mucosa-associated lymphoid tissue (MALT) lymphoma is not associated with an adverse prognosis.
    Ang MK, Hee SW, Quek R, Yap SP, Loong S, Tan L, Tao M, Lim ST.
    Ann Hematol; 2009 May 01; 88(5):417-24. PubMed ID: 18777110
    [Abstract] [Full Text] [Related]

  • 8. The International Prognostic Index assessed at relapse predicts outcomes of autologous transplantation for diffuse large-cell non-Hodgkin's lymphoma in second complete or partial remission.
    Lerner RE, Thomas W, Defor TE, Weisdorf DJ, Burns LJ.
    Biol Blood Marrow Transplant; 2007 Apr 01; 13(4):486-92. PubMed ID: 17382255
    [Abstract] [Full Text] [Related]

  • 9. Diffuse large B-cell lymphoma: clinical and biological characterization and outcome according to the nodal or extranodal primary origin.
    López-Guillermo A, Colomo L, Jiménez M, Bosch F, Villamor N, Arenillas L, Muntañola A, Montoto S, Giné E, Colomer D, Beà S, Campo E, Montserrat E.
    J Clin Oncol; 2005 Apr 20; 23(12):2797-804. PubMed ID: 15728226
    [Abstract] [Full Text] [Related]

  • 10. Prognostic significance of bcl-2, bax, and p53 expression in diffuse large B-cell lymphoma.
    Sohn SK, Jung JT, Kim DH, Kim JG, Kwak EK, Park Ti, Shin DG, Sohn KR, Lee KB.
    Am J Hematol; 2003 Jun 20; 73(2):101-7. PubMed ID: 12749011
    [Abstract] [Full Text] [Related]

  • 11. Identification of outcome predictors in diffuse large B-cell lymphoma. Immunohistochemical profiling of homogeneously treated de novo tumors with nodal presentation on tissue micro-arrays.
    Zinzani PL, Dirnhofer S, Sabattini E, Alinari L, Piccaluga PP, Stefoni V, Tani M, Musuraca G, Marchi E, Falini B, Baccarani M, Pileri SA.
    Haematologica; 2005 Mar 20; 90(3):341-7. PubMed ID: 15749666
    [Abstract] [Full Text] [Related]

  • 12. [Prognosis and treatment strategies of primary B-cell and NK/T-cell nasopharyngeal non-Hodgkin's lymphoma at early stage].
    Zou GR, Zhang YJ, Xie FY, Zheng W, Li HX, Xia YF, Lin TY, Lu TX.
    Ai Zheng; 2006 Dec 20; 25(12):1543-9. PubMed ID: 17166383
    [Abstract] [Full Text] [Related]

  • 13. Primary breast non-Hodgkin's lymphoma: a large single center study of initial characteristics, natural history, and prognostic factors.
    Validire P, Capovilla M, Asselain B, Kirova Y, Goudefroye R, Plancher C, Fourquet A, Zanni M, Gaulard P, Vincent-Salomon A, Decaudin D.
    Am J Hematol; 2009 Mar 20; 84(3):133-9. PubMed ID: 19199367
    [Abstract] [Full Text] [Related]

  • 14. Primary bone lymphoma: treatment results and prognostic factors with long-term follow-up of 82 patients.
    Beal K, Allen L, Yahalom J.
    Cancer; 2006 Jun 15; 106(12):2652-6. PubMed ID: 16700039
    [Abstract] [Full Text] [Related]

  • 15. Cyclin D3 is a predictive and prognostic factor in diffuse large B-cell lymphoma.
    Filipits M, Jaeger U, Pohl G, Stranzl T, Simonitsch I, Kaider A, Skrabs C, Pirker R.
    Clin Cancer Res; 2002 Mar 15; 8(3):729-33. PubMed ID: 11895902
    [Abstract] [Full Text] [Related]

  • 16. Expression of fas (CD95/APO-1) antigen induced by radiation therapy for diffuse B-cell lymphoma: immunohistochemical study.
    Ogawa Y, Nishioka A, Hamada N, Terashima M, Inomata T, Yoshida S, Seguchi H, Kishimoto S.
    Clin Cancer Res; 1997 Dec 15; 3(12 Pt 1):2211-6. PubMed ID: 9815617
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Correlation of high numbers of intratumoral FOXP3+ regulatory T cells with improved survival in germinal center-like diffuse large B-cell lymphoma, follicular lymphoma and classical Hodgkin's lymphoma.
    Tzankov A, Meier C, Hirschmann P, Went P, Pileri SA, Dirnhofer S.
    Haematologica; 2008 Feb 15; 93(2):193-200. PubMed ID: 18223287
    [Abstract] [Full Text] [Related]

  • 19. Prognostic factors in primary gastric lymphoma.
    Medina-Franco H, Germes SS, Maldonado CL.
    Ann Surg Oncol; 2007 Aug 15; 14(8):2239-45. PubMed ID: 17546474
    [Abstract] [Full Text] [Related]

  • 20. Expression of Fas and Fas ligand in cutaneous B-cell lymphomas.
    Zoi-Toli O, Meijer CJ, Oudejans JJ, de Vries E, van Beek P, Willemze R.
    J Pathol; 1999 Dec 15; 189(4):533-8. PubMed ID: 10629554
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 24.